MRSA Assay
Product Overview
The MultNAT MRSA/SA Assay is an automated, in vitro nucleic acid amplification test used for the qualitative detection and differentiation of Staphylococcus aureus (SA) and Methicillin-Resistant Staphylococcus aureus (MRSA) DNA from nasal swab samples of patients at risk for nasal colonization
-
Fast Result: Turnaround time of approximately 62 minutes
-
High Sensitivity: Limit of Detection (LOD) as low as 100~200 CFU/Reaction for various SCCmec type MRSA strains
-
Simple Operation: One-step sample loading, no complex pre-processing or extensive training required
Ongoing Challanges
- Nasal colonization by Methicillin-Resistant Staphylococcus aureus (MRSA) and Staphylococcus aureus (SA) is a critical concern for infection prevention and control in healthcare settings, closely associated with the risk of nosocomial infections
- Treatment options for MRSA infections differ from those for susceptible strains. Early identification of carriers facilitates the implementation of targeted contact precautions and decolonization measures, effectively breaking the chain of transmission
- Rapid and accurate differentiation between MRSA and SA is essential for guiding infection control strategies, optimizing antibiotic use, and improving patient outcomes
Clinical Value
-
Accurate Differentiation: Effectively distinguishes between MRSA and SA nasal colonization, providing crucial molecular evidence for infection control
-
Guides Intervention: Early identification of MRSA carriers aids in timely initiation of contact precautions and decolonization therapy, reducing the risk of nosocomial spread
-
Improves Efficiency: Automated workflow and rapid reporting shorten turnaround time, supporting swift clinical decision-making and patient management
